Evidence map›Paper›PMID 42824794›Full record

ArticleJournal of arrhythmia2026

Procedural Efficiency and Clinical Outcomes of a Region-Specific Radiofrequency Ablation Strategy for Pulmonary Vein Isolation.

Etel Silva, Joaquín Alba-Camacho, Rafael Fernández-Rivero, Lucas Cano-Calabria, Iván Lobo-Torres, Saman Golmaryami, Ana María Solano-Mulero, Juan Fernández-Armenta

Abstract read
In one paragraph

Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Etel SilvaCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.ORCID https://orcid.org/0000-0001-6825-243X
Joaquín Alba-CamachoCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.
Rafael Fernández-RiveroCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.ORCID https://orcid.org/0009-0005-6354-9564
Lucas Cano-CalabriaCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.
Iván Lobo-TorresCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.ORCID https://orcid.org/0000-0002-9950-5628
Saman GolmaryamiCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.ORCID https://orcid.org/0009-0004-5442-8018
Ana María Solano-MuleroCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.ORCID https://orcid.org/0009-0000-2578-6765
Juan Fernández-ArmentaCardiology Department, Institute of Biomedical Research and Innovation of Cádiz (INiBICA) University Hospital Puerta Del Mar Cádiz Spain.ORCID https://orcid.org/0000-0003-1700-6604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-power short-duration radiofrequency ablation improves procedural efficiency during pulmonary vein isolation (PVI), but concerns remain regarding lesion transmurality and posterior wall collateral injury. We evaluated whether a region-specific ablation strategy was associated with improved procedural efficiency without a detected difference in acute efficacy or 12-month arrhythmia recurrence compared with conventional ablation index-guided PVI. Methods: In this retrospective single-center study, 250 patients undergoing first-time PVI were treated with either ablation index-guided ablation or a region-specific strategy using very high-power short-duration applications on the posterior wall and ablation index-guided lesions on the anterior wall. The primary endpoint was first-pass isolation, analyzed per pulmonary vein using generalized estimating equations to account for within-patient clustering. Secondary endpoints included procedural efficiency, peri-procedural safety, and 12-month arrhythmia recurrence. Results: First-pass isolation was achieved in 919 of 1 000 pulmonary veins (91.9%): 454 of 500 veins (90.8%) with the region-specific strategy and 465 of 500 veins (93.0%) with ablation index-guided ablation, with no significant between-group difference (OR, 0.74; 95% CI, 0.41-1.34; Conclusions: A region-specific ablation strategy improved procedural efficiency without a detected difference in first-pass isolation or 12-month arrhythmia recurrence compared with ablation index-guided PVI.

Indexed as

ablation indexatrial fibrillationcatheter ablationhigh‐power short‐duration ablationpulmonary vein isolationregion‐specific ablation

Identifiers

PMID42824794
PMCPMC13629464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.